Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer

The modern management of the axilla in breast cancer relies on surgery for accurate staging of disease and identifying those patients at risk who would benefit from adjuvant chemotherapy. The introduction of sentinel lymph node biopsy has revolutionized axillary surgery, but still involves a surgica...

Full description

Bibliographic Details
Main Authors: Michael Douek, Geoff Charles-Edwards, Laura Johnson
Format: Article
Language:English
Published: MDPI AG 2010-11-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/2/4/1884/
id doaj-1434cb3a698b4a709420a5820f0814ec
record_format Article
spelling doaj-1434cb3a698b4a709420a5820f0814ec2020-11-24T23:49:28ZengMDPI AGCancers2072-66942010-11-01241884189410.3390/cancers2041884Nanoparticles in Sentinel Lymph Node Assessment in Breast CancerMichael DouekGeoff Charles-EdwardsLaura JohnsonThe modern management of the axilla in breast cancer relies on surgery for accurate staging of disease and identifying those patients at risk who would benefit from adjuvant chemotherapy. The introduction of sentinel lymph node biopsy has revolutionized axillary surgery, but still involves a surgical procedure with associated morbidity in many patients with no axillary involvement. Nanotechnology encompasses a broad spectrum of scientific specialities, of which nanomedicine is one. The potential use of dual-purpose nanoprobes could enable imaging the axilla simultaneous identification and treatment of metastatic disease. Whilst most applications of nanomedicine are still largely in the laboratory phase, some potential applications are currently undergoing clinical evaluation for translation from the bench to the bedside. This is an exciting new area of research where scientific research may become a reality. http://www.mdpi.com/2072-6694/2/4/1884/axillary stagingbreast cancernanoparticlessentinel lymph node
collection DOAJ
language English
format Article
sources DOAJ
author Michael Douek
Geoff Charles-Edwards
Laura Johnson
spellingShingle Michael Douek
Geoff Charles-Edwards
Laura Johnson
Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
Cancers
axillary staging
breast cancer
nanoparticles
sentinel lymph node
author_facet Michael Douek
Geoff Charles-Edwards
Laura Johnson
author_sort Michael Douek
title Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
title_short Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
title_full Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
title_fullStr Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
title_full_unstemmed Nanoparticles in Sentinel Lymph Node Assessment in Breast Cancer
title_sort nanoparticles in sentinel lymph node assessment in breast cancer
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2010-11-01
description The modern management of the axilla in breast cancer relies on surgery for accurate staging of disease and identifying those patients at risk who would benefit from adjuvant chemotherapy. The introduction of sentinel lymph node biopsy has revolutionized axillary surgery, but still involves a surgical procedure with associated morbidity in many patients with no axillary involvement. Nanotechnology encompasses a broad spectrum of scientific specialities, of which nanomedicine is one. The potential use of dual-purpose nanoprobes could enable imaging the axilla simultaneous identification and treatment of metastatic disease. Whilst most applications of nanomedicine are still largely in the laboratory phase, some potential applications are currently undergoing clinical evaluation for translation from the bench to the bedside. This is an exciting new area of research where scientific research may become a reality.
topic axillary staging
breast cancer
nanoparticles
sentinel lymph node
url http://www.mdpi.com/2072-6694/2/4/1884/
work_keys_str_mv AT michaeldouek nanoparticlesinsentinellymphnodeassessmentinbreastcancer
AT geoffcharlesedwards nanoparticlesinsentinellymphnodeassessmentinbreastcancer
AT laurajohnson nanoparticlesinsentinellymphnodeassessmentinbreastcancer
_version_ 1725482257114726400